Literature DB >> 9250905

Regression of atypical lymphoid hyperplasia after eradication of Helicobacter pylori.

T Tanahashi1, Y Tatsumi, N Sawai, Y Yamaoka, M Nakajima, T Kodama, K Kashima.   

Abstract

A rare case of endoscopic and histological regression of a gastric lymphoid mucosal lesion after eradication of Helicobacter pylori is reported. A 72-year-old man was suspected of having a low-grade B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma by endoscopic and histological findings. Histology of biopsy specimens showed massive infiltration of atypical lymphocytes and lymphoepithelial lesions. Immunohistochemical staining revealed kappa light chain expression in the infiltrated atypical lymphocytes to be twofold that of lambda light chain. The above diagnosis was thus highly suspected but not confirmed. Antibiotic therapy was given on the basis of evidence of H. pylori infection. Successful eradication of H. pylori resulted in remarkable improvement of endoscopic and histological findings. Follow-up studies were carried out 8 months after eradication, with no evidence of relapse. The eradication of H. pylori appears to be an effective alternative therapy for B-cell lymphoproliferative disease, although longer follow-up and further studies are needed before this treatment can be established.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250905     DOI: 10.1007/bf02934097

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  16 in total

1.  Helicobacter pylori gastritis and gastric MALT-lymphoma.

Authors:  M Stolte
Journal:  Lancet       Date:  1992-03-21       Impact factor: 79.321

2.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.

Authors:  A C Wotherspoon; C Ortiz-Hidalgo; M R Falzon; P G Isaacson
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

3.  Antibiotic treatment for low-grade gastric MALT lymphoma.

Authors:  A C Wotherspoon; C Doglioni; M de Boni; J Spencer; P G Isaacson
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

4.  Healing gastric MALT lymphomas by eradicating H pylori?

Authors:  M Stolte; S Eidt
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

5.  Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.

Authors:  Y Fukuda; I Yamamoto; M Okui; Y Tonokatsu; T Shimoyama
Journal:  J Clin Gastroenterol       Date:  1995       Impact factor: 3.062

6.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

Authors:  A C Wotherspoon; C Doglioni; T C Diss; L Pan; A Moschini; M de Boni; P G Isaacson
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

7.  Evaluation of new therapy for eradication of H. pylori infection in nude mouse model.

Authors:  M Karita; Q Li; K Okita
Journal:  Am J Gastroenterol       Date:  1993-09       Impact factor: 10.864

8.  Malignant lymphoma of mucosa-associated lymphoid tissue.

Authors:  P G Isaacson; J Spencer
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

9.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

10.  Histopathological and immunohistochemical study of atypical lymphoid hyperplasia and benign lymphoid hyperplasia of the stomach.

Authors:  Y Takano; Y Kato; H Sugano
Journal:  Jpn J Cancer Res       Date:  1992-03
View more
  1 in total

1.  Geographical distribution of the incidence of gastric cancer in Bhutan.

Authors:  Tashi Dendup; James M Richter; Yoshio Yamaoka; Kinley Wangchuk; Hoda M Malaty
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.